phenylacetylglutamine has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Q; Pan, R; Tao, R; Yang, Q; Zhuang, L; Zong, X | 1 |
| Barrios, C; Beaumont, M; Bell, JT; Clark, A; Goodrich, JK; Ley, RE; Menni, C; Pallister, T; Pascual, J; Spector, TD; Villar, J | 1 |
2 other study(ies) available for phenylacetylglutamine and Kidney Diseases
| Article | Year |
|---|---|
Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure.
Topics: Chronic Disease; Glutamine; Heart Failure; Humans; Kidney Diseases; Prognosis; Risk Factors | 2022 |
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Clostridiales; Cresols; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diseases in Twins; Feces; Female; Fermentation; Gastrointestinal Microbiome; Glomerular Filtration Rate; Glutamine; Humans; Indican; Kidney Diseases; Male; Metabolome; Microbiota; Middle Aged; Ribotyping; Sulfuric Acid Esters | 2015 |